VERSANT VENTURE CAPITAL VI, L.P. sold 2.90M shares of LAVA THERAPEUTICS NV on the open market
Open‑market sale worth $4.07M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/23/2025ACC: 0001193125-25-213445
10% Owner
Since Jan 2025
-2.90M
Net shares
Net seller
$4.07M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.90M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.37M
Price / share
$1.40
Trade value
$3.32M
% of position
New position
9/19/2025
2.37M→0.00
Common Stock
Indirect
Shares
−532.87K
Price / share
$1.40
Trade value
$746.76K
% of position
New position
9/19/2025
532.87K→0.00
Total
Net shares
−2.90M
Net value
-$4.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/19/2025 | S · Sale | −2.37M | $1.40 | $3.32M | New position | 2.37M | 0.00 |
| Common Stock Indirect | 9/19/2025 | S · Sale | −532.87K | $1.40 | $746.76K | New position | 532.87K | 0.00 |
| Total | −2.90M | -$4.07M | ||||||
Derivative Transactions0
No derivative transactions reported